Since blockade of IFN-γ reduces the systemic cytokine storm in the TLR9 model of MAS (11, 13, 14), we investigated whether IFN-γ blockade could similarly limit pulmonary and airway inflammation. The gene discussed is IFNG; the disease is macrophage activation syndrome.